Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
The appointment was made by the Industries Department on December 24, 2025
The Government of Kerala has nominated Dr Sreeraj Gopi, Founder and Managing Director of Molecules Biolabs, as the Government Nominee on the Board of Directors of Kerala Lifesciences Industries Parks Private Limited (KLIP).
The appointment was made by the Industries Department on December 24, 2025. Dr Sreeraj Gopi’s nomination fills the vacancy created following the resignation of John Kuriakose, who stepped down from the KLIP Board with effect from October 22, 2025.
Dr Sreeraj Gopi is a globally recognised scientist and entrepreneur with an exceptional academic and industrial background. He holds multiple PhDs from Gdańsk University of Technology, Poland, and Deakin University, Australia, and is a Fellow of the Royal Society of Chemistry (RSC), London.
He founded Molecules Biolabs without external financial backing and built it into a global organisation exporting advanced products to over 50 countries, supported by a team of more than 100 professionals. The company is internationally acclaimed for its innovations in liposomal and natural product technologies.
Expanding this vision, Dr Sreeraj also leads Akore Formulations, where he serves as CEO, focusing on next-generation niosomal technologies for cosmetic and pharmaceutical applications.
Dr Sreeraj Gopi has been listed among the world’s top 2% scientists by Stanford University, reflecting his sustained impact on science and technology. He is a Visiting Professor at Shanghai University, an advisor to several nutraceutical and life-science companies, and a sought-after expert in liposome-based drug and nutrient delivery systems.
Known for his commitment to collaboration, mentorship, and translational research, Dr Sreeraj bridges academia and industry to drive innovation, sustainability, and global competitiveness. His nomination to the KLIP Board is expected to further strengthen Kerala’s life sciences ecosystem and reinforce the state’s ambition to emerge as a leading hub for biotechnology and advanced manufacturing.